PRKCA and intestinal neoplasm: PKCα-knockout APCMin/+ mice model display an elevated risk of intestinal tumors,13 suggesting that PKCα suppresses colon cancer development, whereas multiple studies revealed that PKCα confers drug resistance to human CRC cells.26